BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 31035809)

  • 21. Breath-group intelligibility in dysarthria: characteristics and underlying correlates.
    Yunusova Y; Weismer G; Kent RD; Rusche NM
    J Speech Lang Hear Res; 2005 Dec; 48(6):1294-310. PubMed ID: 16478372
    [TBL] [Abstract][Full Text] [Related]  

  • 22. How expertise and language familiarity influence perception of speech of people with Parkinson's disease.
    Verkhodanova V; Coler M; Jonkers R; Lowie W
    Clin Linguist Phon; 2022 Mar; 36(2-3):165-182. PubMed ID: 34809519
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automatic Assessment of Intelligibility in Noise in Parkinson Disease: Validation Study.
    Moya-Galé G; Walsh SJ; Goudarzi A
    J Med Internet Res; 2022 Oct; 24(10):e40567. PubMed ID: 36264608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Visual Analog Scale Ratings and Orthographic Transcription Measures of Sentence Intelligibility in Parkinson's Disease With Variable Listener Exposure.
    Abur D; Enos NM; Stepp CE
    Am J Speech Lang Pathol; 2019 Aug; 28(3):1222-1232. PubMed ID: 31296027
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Speech intelligibility and perceptions of communication effectiveness by speakers with dysarthria following traumatic brain injury and their communication partners.
    McAuliffe MJ; Carpenter S; Moran C
    Brain Inj; 2010; 24(12):1408-15. PubMed ID: 20858025
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of dialect upon the perception of dysarthic speech.
    Dagenais PA; Stallworth JA
    Clin Linguist Phon; 2014; 28(7-8):573-89. PubMed ID: 25000379
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Cross-Language Study of Acoustic Predictors of Speech Intelligibility in Individuals With Parkinson's Disease.
    Kim Y; Choi Y
    J Speech Lang Hear Res; 2017 Sep; 60(9):2506-2518. PubMed ID: 28821018
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acoustic characteristics in relation to intelligibility reduction in noise for speakers with Parkinson's disease.
    Chiu Y; Neel A; Loux T
    Clin Linguist Phon; 2021 Mar; 35(3):222-236. PubMed ID: 32539544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Towards an automatic evaluation of the dysarthria level of patients with Parkinson's disease.
    Vásquez-Correa JC; Orozco-Arroyave JR; Bocklet T; Nöth E
    J Commun Disord; 2018; 76():21-36. PubMed ID: 30149241
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Intelligibility Deficits in Parkinson's Disease With Perceptual Speech Ratings.
    Chiu YF; Neel A
    J Speech Lang Hear Res; 2020 Feb; 63(2):433-443. PubMed ID: 32097080
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sentence-Level Movements in Parkinson's Disease: Loud, Clear, and Slow Speech.
    Kearney E; Giles R; Haworth B; Faloutsos P; Baljko M; Yunusova Y
    J Speech Lang Hear Res; 2017 Dec; 60(12):3426-3440. PubMed ID: 29209727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intelligibility Across a Reading Passage: The Effect of Dysarthria and Cued Speaking Styles.
    van Brenk F; Stipancic K; Kain A; Tjaden K
    Am J Speech Lang Pathol; 2022 Jan; 31(1):390-408. PubMed ID: 34982941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship between acoustic measures and judgments of intelligibility in Parkinson's disease: a within-speaker approach.
    Feenaughty L; Tjaden K; Sussman J
    Clin Linguist Phon; 2014 Nov; 28(11):857-78. PubMed ID: 24874184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Speech and language therapy versus placebo or no intervention for speech problems in Parkinson's disease.
    Herd CP; Tomlinson CL; Deane KH; Brady MC; Smith CH; Sackley CM; Clarke CE
    Cochrane Database Syst Rev; 2012 Aug; 2012(8):CD002812. PubMed ID: 22895930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between acoustic measures and speech naturalness ratings in Parkinson's disease: A within-speaker approach.
    Klopfenstein M
    Clin Linguist Phon; 2015; 29(12):938-54. PubMed ID: 26403503
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Assessing speech intelligibility of pathological speech: test types, ratings and transcription measures.
    Xue W; van Hout R; Cucchiarini C; Strik H
    Clin Linguist Phon; 2023 Jan; 37(1):52-76. PubMed ID: 34955083
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence and pattern of perceived intelligibility changes in Parkinson's disease.
    Miller N; Allcock L; Jones D; Noble E; Hildreth AJ; Burn DJ
    J Neurol Neurosurg Psychiatry; 2007 Nov; 78(11):1188-90. PubMed ID: 17400592
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variation in Speech Intelligibility Ratings as a Function of Speech Rate Modification in Parkinson's Disease.
    Knowles T; Adams SG; Jog M
    J Speech Lang Hear Res; 2021 Jun; 64(6):1773-1793. PubMed ID: 33950711
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysprosody and stimulus effects in Cantonese speakers with Parkinson's disease.
    Ma JK; Whitehill T; Cheung KS
    Int J Lang Commun Disord; 2010; 45(6):645-55. PubMed ID: 19995207
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Communication efficiency of dysarthric speakers as measured by sentence intelligibility and speaking rate.
    Yorkston KM; Beukelman DR
    J Speech Hear Disord; 1981 Aug; 46(3):296-301. PubMed ID: 7278175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.